Public signalCompany raiseAuto-indexed · Unverified

Cadenza Bio, Inc. raised $2.4M

Cadenza Bio, Inc.· YUKON, US· Biotechnology· Filed Aug 28, 2025

Cadenza Bio, Inc. reported raising capital. Based in YUKON, OKLAHOMA, US. First sale reported 2023-12-04. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$2.4M
Confidence90%
Raised
$2.4M
Investors
10
Incorporated
2022
Jurisdiction
DELAWARE

On the record

Location
YUKON, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$2.4M
Target amount
$2.4M
Filing date
Aug 28, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Year incorporated
2022
Industry group
Biotechnology
Number of investors
10
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$2.4M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 2,440,000 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Aug 28, 2025. Details beyond the filing have not been verified.

Tags

USCompanyBiotechnology$1M – $10MCompany Raise

Are you associated with Cadenza Bio, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record